
pmid: 6025902
THROMBOSIS of the axillary and subclavian veins is a rare entity. In the statistical compilation by Barker et al of thromboembolic disease seen at the Mayo Clinic, 1 thrombosis of deep veins of the upper extremity represented only 1.7% of 1,260 cases. In a recent assessment by us of 2,400 episodes of deep venous thrombosis recognized over a 15-year interval, thrombosis of deep veins of the arm constituted 1.3% of the total. The largest single group of cases we have encountered in the medical literature is a series of 46 patients reported by Veal and Hussey in 1943 2 ; these individuals received no specific therapy. During the course of summarizing the results of anticoagulant therapy of deep venous thrombosis at our institution, we were impressed with a prognosis more favorable than expected 2,3 in 33 patients with deep venous thrombosis of the upper extremity who received anticoagulants for treatment of
Nephrotic Syndrome, Heart Diseases, Neoplasms, Physical Exertion, Anticoagulants, Humans, Axillary Vein, Thrombophlebitis, Infections, Subclavian Vein
Nephrotic Syndrome, Heart Diseases, Neoplasms, Physical Exertion, Anticoagulants, Humans, Axillary Vein, Thrombophlebitis, Infections, Subclavian Vein
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 190 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
